In a small group of eight metastatic NSCLC patients treated within the LUX-Lung 3 study, Exon 19 deletion EGFR mutation was detected by the real-time PCR and melting curve analysis protocol and the results were correlated with radiological response. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.